Skip to main content
. 2022 Dec 8;20:477. doi: 10.1186/s12916-022-02678-6

Fig. 6.

Fig. 6

The relationship between E-field, neuroplasticity (structural and functional brain changes), and clinical outcomes. (Left) Insufficient E-field dosing with no changes in depression and cognitive related circuitry. (Middle) Optimal E-field dosing with increased grey matter volume and reduced fALFF in depression circuitry. (Right) Excessive E-field dosing with further reductions in fALFF in cognitive circuitry